(Q38073018)

28 August 2017

title

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions (English)

1 reference

28 August 2017

Lise J Estcourt

1

0 references

Erica M. Wood

object named as

Erica M Wood

7

0 references

Sherrill J Slichter

6

object named as

Sherrill Slichter

1 reference

28 August 2017

8

Simon J Stanworth

1 reference

28 August 2017

Nancy Heddle

2

1 reference

28 August 2017

Richard Kaufman

3

1 reference

28 August 2017

Jeffrey McCullough

4

1 reference

28 August 2017

Michael F Murphy

5

1 reference

28 August 2017

Biomedical Excellence for Safer Transfusion Collaborative

9

1 reference

28 August 2017

publication date

10 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

53

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

1531-1543

1 reference

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

28 August 2017

cites work

1 reference

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

21 January 2018

1 reference

Dose of prophylactic platelet transfusions and prevention of hemorrhage

21 January 2018

1 reference

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic plat

21 January 2018

1 reference

Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.

21 January 2018

1 reference

A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study

21 January 2018

1 reference

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation

21 January 2018

1 reference

A systematic assessment of the quality of reporting for platelet transfusion studies

21 January 2018

1 reference

The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study

21 January 2018

1 reference

Indications for platelet transfusion in children with acute leukemia

21 January 2018

1 reference

Prophylactic Platelet Transfusions in Children with Acute Leukemia: A Dose Response Study

21 January 2018

1 reference

A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.

21 January 2018

1 reference

Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study

21 January 2018

1 reference

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin

21 January 2018

1 reference

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

21 January 2018

1 reference

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.

21 January 2018

1 reference

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

21 January 2018

1 reference

Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses

21 January 2018

1 reference

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

21 January 2018

1 reference

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

21 January 2018

1 reference

Determination of acute lung injury after repeated platelet transfusions

21 January 2018

1 reference

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding

21 January 2018

1 reference

A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia

21 January 2018

1 reference

Time to rethink clinically important outcomes in platelet transfusion trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.12058

1 reference

28 August 2017

1 reference